We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLV:BVBBanca Transilvania SA Analysis

Data as of 2026-03-11 - not real-time

RON 35.26

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Banca Transilvania delivered a 16% year‑on‑year profit surge in 2025, pushing trailing earnings per share to 4.28 RON and driving a robust 26.5% revenue growth. The stock trades at a forward PE of around 9.6, far below the industry average of 17.3, while the price‑to‑book ratio sits at 2.05, suggesting the market may be undervaluing its solid balance sheet. A dividend yield of nearly 6% with a payout ratio under 50% underscores the sustainability of its cash returns. Technically, the price of 35.26 RON is above the 20‑day SMA (34.93) and the 50‑day SMA (33.51), the 200‑day SMA (29.26) remains well below, and volume is on an upward trend, all pointing to a bullish bias despite a bearish MACD histogram.
The bank’s low beta (~0.27) indicates limited sensitivity to market swings, though a 30‑day volatility of ~28% injects moderate price fluctuation risk. Strong operating margins (≈50%) and an ROE of 22.9% reinforce its resilience, while geographic concentration in Romania, Italy and Moldova imposes medium‑level country risk. Overall, the combination of attractive valuation, high dividend yield, and solid fundamentals supports a positive outlook across short, medium and long horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day and 50‑day SMAs indicating bullish momentum
  • Strong earnings growth and profit expansion
  • High dividend yield with sustainable payout

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics relative to peers
  • Consistent operating margins and ROE
  • Target price consensus near current levels

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta and defensive banking profile
  • Solid capital base and manageable debt levels
  • Attractive dividend yield coupled with growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth26.50%
Profit Margin42.54%
P/E Ratio8.2
ROE22.88%
ROA2.16%
P/B Ratio2.1
Industry P/E17.3

Technical Analysis

TrendBullish
RSI56.8
SupportRON 33.22
ResistanceRON 36.82
MA 20RON 34.93
MA 50RON 33.51
MA 200RON 29.26
MACDBearish
VolumeIncreasing
Fear & Greed Index75.98

Valuation

Target PriceRON 35.60
Upside/Downside0.96%
GradeUndervalued
TypeBlend
Dividend Yield5.97%

Risk Assessment

Beta0.27
Volatility27.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.